May 7th, 2019
Harvard University, Broad Institute extend CRISPR human therapeutics license to Verve Therapeutics
Agreement enables development of genome-based therapies to protect against heart disease in adults
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Therapeutics
March 13th, 2019
Harvard and Deerfield establish Lab1636, a major translational research alliance
Deerfield commits $100M to inject fuel into translational life science research at Harvard
October 19th, 2017
Heading off the post-antibiotic age
Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance
August 24th, 2016
An agent of demise
Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease
March 21st, 2016
Blavatnik Biomedical Accelerator at Harvard University announces license and collaboration agreement
Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.
